These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36834588)

  • 1. Gut Microbiota Deficiency Exacerbates Liver Injury in Bile Duct Ligated Mice via Inflammation and Lipid Metabolism.
    Zhou X; Zhang X; Zhao N; Zhang L; Qiu W; Song C; Chai J; Cai S; Chen W
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns.
    Juanola O; Hassan M; Kumar P; Yilmaz B; Keller I; Simillion C; Engelmann C; Tacke F; Dufour JF; De Gottardi A; Moghadamrad S
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33847205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis.
    Xie XM; Feng S; Liu T; Feng J; Xu Y; Fan ZJ; Wang GY
    Int Immunopharmacol; 2024 Sep; 139():112747. PubMed ID: 39067396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.
    Gao Y; Zhai W; Sun L; Du X; Wang X; Mulholland MW; Yin Y; Zhang W
    Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G460-G472. PubMed ID: 38440827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
    Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
    Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice.
    Yang X; Xu Y; Li J; Ran X; Gu Z; Song L; Zhang L; Wen L; Ji G; Wang R
    mSystems; 2024 Jul; 9(7):e0012724. PubMed ID: 38934542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
    Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction.
    Yang B; Sun T; Chen Y; Xiang H; Xiong J; Bao S
    Front Microbiol; 2022; 13():909461. PubMed ID: 35620109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis.
    López-Sánchez LM; Corrales FJ; Barcos M; Espejo I; Muñoz-Castañeda JR; Rodríguez-Ariza A
    Lab Invest; 2010 Jan; 90(1):116-27. PubMed ID: 19806079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of cholestatic liver injury and intestinal permeability by lubiprostone treatment in bile duct ligated rats: role of intestinal FXR and tight junction proteins claudin-1, claudin-2, and occludin.
    Safari F; Sharifi M; Talebi A; Mehranfard N; Ghasemi M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2009-2022. PubMed ID: 36897372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice.
    Ozeki J; Uno S; Ogura M; Choi M; Maeda T; Sakurai K; Matsuo S; Amano S; Nebert DW; Makishima M
    Toxicology; 2011 Feb; 280(1-2):10-7. PubMed ID: 21095216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
    Almishri W; Swain LA; D'Mello C; Le TS; Urbanski SJ; Nguyen HH
    Front Immunol; 2021; 12():779119. PubMed ID: 35095853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance.
    Remetic J; Ghallab A; Hobloss Z; Brackhagen L; Hassan R; Myllys M; Radun R; Mlitz V; Zhu C; Baumgartner M; Schrottmaier WC; Mussbacher M; Timelthaler G; Scharnagl H; Stojakovic T; Assinger A; Fuchs CD; Hengstler JG; Trauner M
    Hepatology; 2022 May; 75(5):1095-1109. PubMed ID: 34927748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effect of
    Bae UJ; Park BH; Cho MK; Bae EJ
    J Med Food; 2022 Jun; 25(6):652-659. PubMed ID: 35708629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin Exhibits Hepatoprotective Effects Against Bile Duct Ligation-induced Liver Injury in Rats: A Combined Molecular Docking Approach to In Vivo Studies.
    Shakerinasab N; Azizi M; Mansourian M; Sadeghi H; Salaminia S; Abbasi R; Shahaboddin ME; Doustimotlagh AH
    Curr Pharm Des; 2022; 28(40):3313-3323. PubMed ID: 36305136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.